Sequrna Overview
- Year Founded
-
2022
- Status
-
Private
- Latest Deal Type
-
Corporate
- Financing Rounds
-
1
Sequrna General Information
Description
Provider of biotechnology products based in Stockholm, Sweden. The company's RNase inhibitor makes RNA work and sequencing pipelines more accessible, affordable, and sustainable, simplifying shipping and storage logistics, eliminating batch effects and enabling new workflows and novel laboratory protocols, including heat cycles.
Contact Information
Website
www.sequrna.comCorporate Office
- Nanna Svartz Väg 4
- 171 65 Stockholm
- Sweden
Corporate Office
- Nanna Svartz Väg 4
- 171 65 Stockholm
- Sweden
Sequrna Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sequrna Patents
Sequrna Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4519432-A1 | Methods and uses of ribonuclease inhibitors | Pending | 05-May-2022 |
Sequrna Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Sequrna FAQs
-
When was Sequrna founded?
Sequrna was founded in 2022.
-
Where is Sequrna headquartered?
Sequrna is headquartered in Stockholm, Sweden.
-
What industry is Sequrna in?
Sequrna’s primary industry is Biotechnology.
-
Is Sequrna a private or public company?
Sequrna is a Private company.
-
What is Sequrna’s current revenue?
The current revenue for Sequrna is .
-
Who are Sequrna’s investors?
Genovis has invested in Sequrna.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
